Preleukemic AML1/ETO-expressing hematopoietic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation; Evidence for multistep leukemogenesis.

被引：0
|
作者：
Miyamoto, T
Weissman, IL
Akashi, K
机构：
[1] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3057
引用
收藏
页码：691A / 691A
页数：1
相关论文
共 50 条
  • [41] Relapsed/Refractory AML1::ETO Acute Myeloid Leukemia Was Successfully Treated By Allogeneic Hematopoietic Stem Cell Transplantation with Modifyed Myeloablative Preconditioning Contains Olaparib
    Xue, Song
    Lu, Peihua
    Cao, Xingyu
    BLOOD, 2024, 144 : 7321 - 7322
  • [42] AML1/ETO Proteins Control POU4F1/BRN3A Expression and Function in t(8;21) Acute Myeloid Leukemia
    Dunne, Jenny
    Gascoyne, Duncan M.
    Lister, T. Andrew
    Brady, Hugh J. M.
    Heidenreich, Olaf
    Young, Bryan D.
    CANCER RESEARCH, 2010, 70 (10) : 3985 - 3995
  • [43] Minimal residual disease in acute myelogenous leukemia with PML/RARα or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow
    Inokuchi, K
    Iwakiri, R
    Futaki, M
    Hanawa, H
    Tanosaki, S
    Nomura, T
    Dan, K
    LEUKEMIA & LYMPHOMA, 1998, 29 (5-6) : 553 - 561
  • [44] The residual malignant cells could be masked by therapeutic use of granulocyte-colony stimulating factor in the patients with AML1/ETO+ acute myelogenous leukemia.
    Moon, HW
    Kim, HY
    Kim, YR
    Cho, HI
    Yoon, SS
    Park, S
    Kim, BK
    Chun, H
    Kim, HC
    Lee, DS
    BLOOD, 2005, 106 (11) : 206B - 207B
  • [45] The t(8;21) fusion protein, AML1–ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia
    Bryan Linggi
    Carsten Müller-Tidow
    Louis van de Locht
    Ming Hu
    John Nip
    Hubert Serve
    Wolfgang E. Berdel
    Bert van der Reijden
    Dawn E. Quelle
    Janet D. Rowley
    John Cleveland
    Joop H. Jansen
    Pier Paolo Pandolfi
    Scott W. Hiebert
    Nature Medicine, 2002, 8 : 743 - 750
  • [46] AML1/ETO REPRESSES THE EXPRESSION OF A POTENTIAL TUMOR SUPPRESSOR, CST7, IN T(8;21) ACUTE MYELOID LEUKEMIA THROUGH DNA METHYLATION
    Li, Yizhen
    Wang, Kankan
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (09) : S87 - S88
  • [47] Simultaneous PML/RARα and AML1/ETO expression with t(15;17) at onset and relapse with only t(8;21) in an acute promyelocytic leukemia patient
    Bonomi, R
    Giordano, H
    Moreno, MD
    Bodega, E
    Landoni, AI
    Gallagher, R
    Uriarte, MD
    CANCER GENETICS AND CYTOGENETICS, 2000, 123 (01) : 41 - 43
  • [48] LONG-TERM OUTCOME OF PEDIATRIC AML1/ETO POSITIVE ACUTE MYELOID LEUKEMIA FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN FIRST COMPLETE REMISSION
    Son, Meong Hi
    Lee, Soo Hyun
    Yoo, Keon Hee
    Sung, Ki Woong
    Chueh, Hee Won
    Koo, Hong Hoe
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1039 - 1039
  • [49] t(8;21)(q22;q22) Translocation Involving AML1 and ETO in B Lymophoblastic Leukemia (vol 2, pg 286, 2010)
    Wang, Huan-You
    Tirado, Carlos A.
    HUMAN PATHOLOGY, 2010, 41 (04) : 620 - 620
  • [50] AML1/ETO and POU4F1 synergy drives B-lymphoid gene expression typical of t(8;21) acute myeloid leukemia
    J Dunne
    D Mannari
    T Farzaneh
    A Gessner
    F W van Delft
    O Heidenreich
    B D Young
    D M Gascoyne
    Leukemia, 2012, 26 : 1131 - 1135
12345